These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8154890)

  • 1. [A comparative study on the serum and tissue 5-FU concentrations in patients with hepatocellular carcinoma after preoperative oral administration of UFT and 5'-DFUR].
    Miyazaki K; Yakushiji H; Kitahara K; Mori M; Sasatomi E; Tsutsumi N; Hirohashi Y; Iwanaga A; Iyama A; Fukagawa H
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):641-5. PubMed ID: 8154890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [5-FU concentrations in the blood and tumor tissue after 5'-DFUR or UFT administration in the patients with uterine cervical cancer].
    Suzuki M; Aida I; Ohwada M; Sato I; Tamura T; Kasuga Y
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):253-8. PubMed ID: 7857101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration].
    Suenaga M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3313-8. PubMed ID: 2825604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The serum and tissue concentration of FT-207, 5'-DFUR and 5-FU in patients with breast cancer by preoperative administration of UFT and 5'-DFUR].
    Kosaka A; Sumiyoshi K; Ando J
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):277-80. PubMed ID: 2521996
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study on the pharmacokinetics of UFT in patients with hepatocellular carcinoma associated with cirrhosis].
    Une Y; Ito Y; Ogasawara K; Nagafuchi E; Matsuoka S; Misawa K; Sato N; Nakajima Y; Uchino J
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3153-9. PubMed ID: 2551251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
    Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [FT, 5-FU and uracil concentrations of the blood, bile and tissue of hepatoma with liver cirrhosis after oral administration of UFT].
    Oguma S; Sakai K; Sato R; Ouchi K; Owada Y; Sato T
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1122-8. PubMed ID: 3032114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [5-FU concentration in the serum and the tumor tissue after administration of UFT 200 mg/day to patients over 80 years of age with oral cancer].
    Iida A; Takagi R; Hoshina H; Ono K; Kaji M; Tsurumaki H; Fukuda J; Nagashima K; Miyaura Y; Hayatsu M; Miyamoto T
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1527-32. PubMed ID: 11015997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tissue UFT distribution and histological changes following UFT administration in metastatic liver cancer cases].
    Yoshikawa K; Iwasaki T; Amemiya A; Emoto T; Fujii M; Han N; Itou A; Tsujimura T
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1333-7. PubMed ID: 2114828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Fluorouracil concentration in blood, liver and tumor tissues and apoptosis of tumor cells after preoperative oral 5'-deoxy-5-fluorouridine in patients with hepatocellular carcinoma.
    Zheng JF; Wang HD
    World J Gastroenterol; 2005 Jul; 11(25):3944-7. PubMed ID: 15991299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concentration of 5-fluorouracil in the blood and tissues of gastric and colo-rectal cancer patients after oral administration of UFT].
    Inaba S; Kondo Y; Tsuchiya K; Kawai K; Ogino A; Umeda T; Ueda Y
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2175-80. PubMed ID: 1444483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tissue and serum levels of 5-FU in the patients with head and neck malignant tumors--influence of a streptococcal preparation OK-432].
    Suzuki K; Itaya S; Tsuge I; Matsuda T; Motai H; Kobayashi T; Shimada J; Baba S
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1349-54. PubMed ID: 8346933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood and tumor levels of tegafur, 5-fluorouracil, and uracil].
    Takeshita T; Iwasaki M; Narita M; Sou M; Sato M; Hashimoto T; Kameya S; Iigima N
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3053-8. PubMed ID: 3142365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Portal-transfer of an orally administered anti-cancer agent analysis of the time course of portal blood and systemic blood levels of preoperatively administered UFT].
    Yoshikawa K; Hashimoto T; Yamaguchi T; Dousei T; Moriguchi S; Taniguchi M; Ueda H; Taketani S; Utsumi T; Suhara H
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):501-5. PubMed ID: 8129391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of tissue drug concentration of fluorinated pyrimidine anticancer drugs--comparison of 5'DFUR and UFT].
    Fukamura T; Umeno T; Jyozaki H; Haruta J; Okamoto K; Hashimoto M; Arima S; Shimura H
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1887-92. PubMed ID: 2144106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of urinary tegafur, 5-fluorouracil (5-FU) and uracil concentrations in the cases of gastric carcinoma for the confirmation of drug-taking compliance after UFT oral administration].
    Ohsawa S; Kondo Y; Shiroto H; Masuko H; Fukushima T; Kataoka A; Ohmori K; Sawaguchi Y; Baba E; Takahashi T
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2189-93. PubMed ID: 1444485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on 5-FU concentration in serum and prostate cancer tissue after oral administration of UFT].
    Shinoda I; Takahashi Y; Takeuchi T; Kuriyama M; Ban Y; Kawada Y; Ito Y; Yamamoto N; Maeda S; Tada K
    Hinyokika Kiyo; 1991 Jul; 37(7):711-5. PubMed ID: 1927771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of OK-432 on intratumor 5-fluorouracil concentration in cases given UFT].
    Sinmyo K; Hosoi H; Suwa H; Kitagawa M; Yamaguchi K; Susaki H
    Gan To Kagaku Ryoho; 1989 May; 16(5):2051-7. PubMed ID: 2499267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of OK-432 on UFT activation].
    Yamamoto Y; Amano T; Imada T; Tamura S; Abe M; Matsumoto A
    Gan No Rinsho; 1988 May; 34(6):749-54. PubMed ID: 3132564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.